Big Technology Podcast Inside The Theranos Trial — With Erin Griffith of The New York Times
Sep 15, 2021
Erin Griffith, a New York Times reporter covering the Theranos trial, provides insider insights into the courtroom drama surrounding Elizabeth Holmes. She discusses the deceptive claims behind Theranos’ blood testing technology and the ethical implications for Silicon Valley. Erin explores whether Holmes represents typical startup risks or if she's an outlier, and examines the ripple effects on female founders in biotech. Her analysis highlights the scrutiny women entrepreneurs face in a challenging funding landscape.
AI Snips
Chapters
Books
Transcript
Episode notes
Trial Attendance
- Erin Griffith attends Elizabeth Holmes' trial, arriving at 5 a.m.
- The courtroom is small, and interest is high, creating a competitive atmosphere.
Rare Trial
- Venture-backed tech executives rarely face legal consequences for unmet promises.
- This case is unusual because Elizabeth Holmes faces trial for misleading investors.
Silicon Valley Promises
- Silicon Valley thrives on ambitious promises, sometimes blurring ethical lines.
- Theranos' case is particularly problematic due to health risks and financial implications.
